EBAC
Price:
$11.19
Market Cap:
$183.50M
European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.
Industry
Shell Companies
IPO Date
2021-05-11
Stock Exchange
NASDAQ
Ticker
EBAC
According to European Biotech Acquisition Corp.’s latest financial reports and current stock price. The company's current PE Ratio is 559.50. This represents a change of 960.83% compared to the average of 52.74 of the last 4 quarters.
The mean historical PE Ratio of European Biotech Acquisition Corp. over the last ten years is 29.55. The current 559.50 PE Ratio has changed 189.22% with respect to the historical average. Over the past ten years (40 quarters), EBAC's PE Ratio was at its highest in in the September 2022 quarter at 188.76. The PE Ratio was at its lowest in in the December 2022 quarter at -41.83.
Average
29.55
Median
29.55
Minimum
22.34
Maximum
36.77
Discovering the peaks and valleys of European Biotech Acquisition Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 64.56%
Maximum Annual PE Ratio = 36.77
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = 22.34
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | 36.77 | 64.56% |
The current PE Ratio of European Biotech Acquisition Corp. (EBAC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
29.55
5-year avg
29.55
10-year avg
29.55
European Biotech Acquisition Corp.’s PE Ratio is greater than AP Acquisition Corp. (66.62), less than Bridgetown Holdings Limited (0), greater than Direxion Daily COIN Bull 2X ETF (1.34), greater than Tristar Acquisition I Corp. (37.23), greater than SK Growth Opportunities Corporation (36.42), greater than Parabellum Acquisition Corp. (6.50), greater than G Squared Ascend II Inc. (13.39), greater than Zapata Computing Holdings Inc. Common Stock (-0.02),
| Company | PE Ratio | Market cap |
|---|---|---|
| 66.62 | $178.79M | |
| 0 | $184.30M | |
| 1.34 | $0 | |
| 37.23 | $187.64M | |
| 36.42 | $179.98M | |
| 6.50 | $178.79M | |
| 13.39 | $187.59M | |
| -0.02 | $5.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like European Biotech Acquisition Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like European Biotech Acquisition Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is European Biotech Acquisition Corp.'s PE Ratio?
How is the PE Ratio calculated for European Biotech Acquisition Corp. (EBAC)?
What is the highest PE Ratio for European Biotech Acquisition Corp. (EBAC)?
What is the 3-year average PE Ratio for European Biotech Acquisition Corp. (EBAC)?
What is the 5-year average PE Ratio for European Biotech Acquisition Corp. (EBAC)?
How does the current PE Ratio for European Biotech Acquisition Corp. (EBAC) compare to its historical average?